Is prostate cancer screening bad or good? Summary of a debate at the innovation in urology meeting, September 17-19, 2010, Milan, Italy.
作者信息
Roobol Monique J
出版信息
Eur Urol. 2011 Mar;59(3):359-62. doi: 10.1016/j.eururo.2010.10.036. Epub 2010 Oct 26.
PMID:21035943
Abstract
摘要
相似文献
1
Is prostate cancer screening bad or good? Summary of a debate at the innovation in urology meeting, September 17-19, 2010, Milan, Italy.前列腺癌筛查是好还是坏？2010年9月17 - 19日于意大利米兰举行的泌尿外科学创新会议上一场辩论的总结。
Eur Urol. 2011 Mar;59(3):359-62. doi: 10.1016/j.eururo.2010.10.036. Epub 2010 Oct 26.
2
Is population screening for prostate cancer good or bad?对前列腺癌进行人群筛查是好还是坏？
Eur Urol. 2011 Mar;59(3):363-4. doi: 10.1016/j.eururo.2010.11.027. Epub 2010 Dec 1.
3
Screening for prostate cancer: practical analysis of the ERSPC [corrected] and PLCO trials.前列腺癌筛查：ERSPC[已修正]和PLCO试验的实践分析
Eur Urol. 2011 Mar;59(3):365-9. doi: 10.1016/j.eururo.2010.11.032. Epub 2010 Dec 1.
4
Prostate cancer mortality rates compared to urologist population densities and prostate-specific antigen screening levels on a state-by-state basis in the United States of America.在美国，按州比较前列腺癌死亡率与泌尿科医生人口密度及前列腺特异性抗原筛查水平。
Prostate Cancer Prostatic Dis. 2008;11(3):247-51. doi: 10.1038/pcan.2008.7. Epub 2008 Feb 12.
5
Why the evidence for skin cancer screening is insufficient: lessons from prostate cancer screening.为何皮肤癌筛查的证据不充分：来自前列腺癌筛查的教训。
Arch Dermatol. 2010 Mar;146(3):322-4. doi: 10.1001/archdermatol.2010.18.
6
New trial data do not end the PSA screening debate.新的试验数据并未终结前列腺特异性抗原（PSA）筛查的争论。
J Natl Cancer Inst. 2009 Jun 16;101(12):844-5. doi: 10.1093/jnci/djp170. Epub 2009 Jun 9.
7
Prostate-cancer screening.前列腺癌筛查。
N Engl J Med. 2009 Jul 9;361(2):202; author reply 204-5. doi: 10.1056/NEJMc090849.
8
Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).前列腺癌的检测：欧洲前列腺癌筛查随机研究（ERSPC）的影响
Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3.
9
Influence of publication of US and European prostate cancer screening trials on PSA testing practices.美国和欧洲前列腺癌筛查试验的发表对 PSA 检测实践的影响。
J Natl Cancer Inst. 2011 Mar 16;103(6):520-3. doi: 10.1093/jnci/djr007. Epub 2011 Feb 28.
10
Efficacy vs effectiveness in prostate-specific antigen screening.前列腺特异性抗原筛查中的效能与效果
J Natl Cancer Inst. 2010 Mar 3;102(5):288-9. doi: 10.1093/jnci/djq002. Epub 2010 Feb 8.
引用本文的文献
1
Prediction models for prostate cancer to be used in the primary care setting: a systematic review.用于初级保健环境中的前列腺癌预测模型：系统评价。
BMJ Open. 2020 Jul 19;10(7):e034661. doi: 10.1136/bmjopen-2019-034661.
2
Personalized management in low-risk prostate cancer: the role of biomarkers.低风险前列腺癌的个性化管理：生物标志物的作用
Prostate Cancer. 2012;2012:327104. doi: 10.1155/2012/327104. Epub 2012 Dec 13.
Zotero 插件